MoESurv achieves a 4% higher C-index than existing models in predicting survival for seven rare cancer types using a zero-sample, transfer learning approach.
- 2 cites
Moving in Bioinformatics.
Rebuilt
MoESurv achieves a 4% higher C-index than existing models in predicting survival for seven rare cancer types using a zero-sample, transfer learning approach.
Newest first · last 60 days
AI-driven multimodal models improve prediction of recurrence and survival in liver cancer, surpassing single-modality approaches in accuracy.
3D multi-omics tumour atlases reveal complex cellular interactions and evolution, offering new insights into tumor biology and potential clinical applications.
General-purpose multimodal large language models in histopathology exhibit errors and hallucinations in over 80% of outputs, impacting diagnostic safety and reliability.
EAGLE AI model detects early esophageal cancer with 90% sensitivity and 98.5% specificity from chest CT scans across multiple centers, enabling scalable screening.
RADAR, a generalist AI trained on over 400,000 abdominal CTs, achieves expert-level diagnosis across 18 structures and 146 findings, with high accuracy and robustness.
Deep learning combined with label-free fluorescence lifetime imaging achieves a 0.966 accuracy in predicting EGFR mutations in lung adenocarcinoma tissues.
CRISP, a clinically oriented foundation model trained on over 100,000 frozen sections, achieves 92.6% diagnostic accuracy in intraoperative pathology across diverse cases.
Detection of tumor-specific HPV-human DNA junctions in serum predicts cervical cancer recurrence with higher accuracy than HPV type alone.
Ultrasound radiomics combined with an immune-related gene signature predicts melanoma response to immune checkpoint inhibitors with 78-88% accuracy.
Counterfactual diffusion models like MoPaDi enable interpretable explanations by revealing morphological features linked to AI predictions in pathology, with 4 datasets spanning multiple cancers.
AI models using clinical and blood data achieved up to 0.77 AUC in NSCLC treatment prediction, outperforming traditional clinical scores in the largest real-world study to date.
Non-invasive imaging of cancer hallmarks enables real-time monitoring and stratification of tumors, with some techniques already impacting clinical treatment decisions.
Stakeholders prioritize clinical benefits and efficiency gains over challenges and safeguards, with 8 key themes identified for AI implementation in cancer care.
RCC-AID provides an open, annotated CT dataset of 129 renal cell carcinoma cases, enabling reproducible AI research with detailed lesion masks for 91 patients.
Journals this month
Moving areas, week to 3 Oct 2026